G49108TO
| Organisms | Evidence |
|---|---|
| Streptococcus pneumoniae | |
| Mus musculus (house mouse) | |
| Saccharomyces cerevisiae (brewer's yeast) | |
| Sus scrofa (pig) | |
| Rattus norvegicus (Norway rat) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-thio-p-Nitrophenyl |
|
[beta]-1-thio-p-Nitrophenyl | |
| B4GALT3 | UDP-Gal |
|
4-Me-lumbelyl-[beta] |
|
4-Me-lumbelyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl | |
| B4GALT1 | UDP-Gal |
|
|
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| Q9JMD0 | BUB3-interacting and GLEBS motif-containing protein ZNF207 | ||
| Q9LD55 | Eukaryotic translation initiation factor 3 subunit A | ||
| Q9LFD5 | Binding partner of ACD11 1 | ||
| Q9LHG0 | At3g12480/MQC3.32 | ||
| Q9LIH5 | Zinc finger CCCH domain-containing protein 38 | ||
| Q9LJE5 | YTH domain-containing protein ECT2 | ||
| Q9LJX4 | Pumilio homolog 5 | ||
| Q9LKA4 | UBP1-associated protein 2C | ||
| Q9LM88 | At1g20670 | ||
| Q9LNJ5 | Transcription factor bHLH13 |
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Gallus gallus |
| Antimicrobial peptides | Homo sapiens |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Xenopus tropicalis |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 38867194 | Hyaluronic acid as a pulpotomy material in primary molars: an up to 30 months retrospective study | Sezgin BI | 2024 Jun 12 |
|
| 38849989 | Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1 | Malinge P | 2024 Jun 07 |
|
| 38642076 | Interactions of Phenylalanine Derivatives with Human Tyrosinase: Lessons from Experimental and Theoretical Studies | Faure C | 2024 Jun 07 |
|
| 38892474 | O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy | Dong W | 2024 Jun 06 |
|
| 38761800 | Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans | Williams WB | 2024 Jun 06 |
|
| 38838737 | Structure and topography of the synaptic V-ATPase–synaptophysin complex | Wang C | 2024 Jun 05 |
|
| 38728868 | Analogues of the pan-selectin antagonist rivipansel (GMI-1070) | Wagner B | 2024 Jun 05 |
|
| 38838015 | OGA mutant aberrantly hydrolyzes O-GlcNAc modification from PDLIM7 to modulate p53 and cytoskeleton in promoting cancer cell malignancy | Hu CW | 2024 Jun 05 |
|
| 38830098 | Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model | Chang Z | 2024 Jun 03 |
|
| 38830870 | O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblasts | Very N | 2024 Jun 03 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025